4,284 Shares in Exponent, Inc. (NASDAQ:EXPO) Purchased by AssuredPartners Investment Advisors LLC

AssuredPartners Investment Advisors LLC purchased a new stake in shares of Exponent, Inc. (NASDAQ:EXPO) in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 4,284 shares of the business services provider’s stock, valued at approximately $382,000.

A number of other large investors have also added to or reduced their stakes in EXPO. Raymond James Financial Inc. bought a new position in shares of Exponent during the 4th quarter valued at approximately $55,131,000. JPMorgan Chase & Co. lifted its stake in Exponent by 63.6% in the third quarter. JPMorgan Chase & Co. now owns 630,644 shares of the business services provider’s stock valued at $72,701,000 after purchasing an additional 245,086 shares during the last quarter. Geode Capital Management LLC grew its holdings in Exponent by 4.8% during the third quarter. Geode Capital Management LLC now owns 1,505,652 shares of the business services provider’s stock valued at $173,597,000 after purchasing an additional 69,099 shares during the period. Vanguard Group Inc. increased its position in Exponent by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 5,345,503 shares of the business services provider’s stock worth $476,284,000 after buying an additional 67,296 shares during the last quarter. Finally, Barclays PLC raised its stake in shares of Exponent by 219.0% in the third quarter. Barclays PLC now owns 96,526 shares of the business services provider’s stock valued at $11,127,000 after buying an additional 66,263 shares during the period. Hedge funds and other institutional investors own 92.37% of the company’s stock.

Exponent Stock Performance

EXPO stock opened at $82.23 on Friday. The stock has a fifty day moving average of $86.78 and a 200-day moving average of $95.75. Exponent, Inc. has a fifty-two week low of $77.30 and a fifty-two week high of $115.75. The company has a market capitalization of $4.18 billion, a price-to-earnings ratio of 38.79 and a beta of 0.77.

Exponent (NASDAQ:EXPO) last issued its earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same quarter last year, the firm earned $0.41 earnings per share. Equities analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.

Insider Buying and Selling

In other Exponent news, VP Richard Reiss sold 1,736 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now owns 1,800 shares in the company, valued at $154,674. This represents a 49.10 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 2.10% of the stock is owned by insiders.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.